LBX Pharmacy Chain Joint Stock Company (SHA:603883)

China · Delayed Price · Currency is CNY

14.48

-0.12 (-0.82%)

Oct 29, 2026, 2:14 PM CST

Market Cap	10.99B -13.1%
Revenue (ttm)	22.82B +2.8%
Net Income	470.90M +12.8%
EPS	0.61 +11.5%
Shares Out	758.89M
PE Ratio	23.65
Forward PE	18.14
Dividend	0.41 (2.83%)
Ex-Dividend Date	Sep 10, 2026

Volume	6,300,810
Open	14.49
Previous Close	14.60
Day's Range	14.33 - 14.61
52-Week Range	10.67 - 17.96
Beta	0.42
Analysts	Buy
Price Target	18.85 (+30.18%)
Earnings Date	Oct 27, 2026

About SHA:603883

LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The company is also involved in wholesale and retail of pharmaceutical products; Chinese medicine research and development; e-commerce; food and departmen... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 2001

Employees 36,892

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603883

Full Company Profile

Financial Performance

In 2025, SHA:603883's revenue was 22.24 billion, a decrease of -0.54% compared to the previous year's 22.36 billion. Earnings were 381.85 million, a decrease of -26.44%.

Financial Statements

Analyst Summary

According to 13 analysts, the average rating for 603883 stock is "Buy." The 12-month stock price target is ¥18.85, which is an increase of 30.18% from the latest price.

Price Target

¥18.85

(30.18% upside)

Analyst Consensus: Buy

Stock Forecasts